1. Home
  2. CRSR vs IOVA Comparison

CRSR vs IOVA Comparison

Compare CRSR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

HOLD

Current Price

$6.84

Market Cap

986.3M

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.27

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSR
IOVA
Founded
1994
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
986.3M
968.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CRSR
IOVA
Price
$6.84
$2.27
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
$9.94
$10.36
AVG Volume (30 Days)
1.1M
11.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,449,248,000.00
$250,425,000.00
Revenue This Year
$12.96
$60.94
Revenue Next Year
$9.28
$60.85
P/E Ratio
N/A
N/A
Revenue Growth
9.79
175.62
52 Week Low
$5.35
$1.64
52 Week High
$13.02
$9.30

Technical Indicators

Market Signals
Indicator
CRSR
IOVA
Relative Strength Index (RSI) 53.46 49.35
Support Level $6.47 $2.16
Resistance Level $6.84 $2.34
Average True Range (ATR) 0.32 0.14
MACD 0.17 -0.02
Stochastic Oscillator 94.03 38.46

Price Performance

Historical Comparison
CRSR
IOVA

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: